Medico Intercontinental has informed that the Company has received disclosure dated 11th October, 2022 under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from Dilipkumar Bhogilal Shah, Promoter and CEO of the Company, in respect of allotment of Equity Shares through preferential issue of Medico Intercontinental on 10th October, 2022. Accordingly, the Company has enclosed copy of the above disclosure.
The above information is a part of company’s filings submitted to BSE.